Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 1
A Phase 1b, Open-label Trial to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of NDI-5001 in a Capsule Following Daily Oral Doses to Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus
The primary purpose of this trial is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of NDI-5001 administered as a capsu…
Diabetes Insipidus
Estimated
~$10 – $8,750
Otsuka Pharmaceutical Development & Commercialization, Inc.NCT07525960
Phase 2
A Phase II Trial Evaluating Chemotherapy Followed by Response-Based Reduced Radiation Therapy for Patients With Central Nervous System Germinomas
This phase II trial studies how well lower dose radiotherapy after chemotherapy (Carboplatin \& Etoposide) works in treating children with central nervous syst…
Basal Ganglia GerminomaDiabetes InsipidusGerminoma+3 more
Estimated
~$10 – $7,500
Children's Oncology GroupNCT06368817
Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study
In this study, the investigators hypothesize that studying monogenic variants with strong effect associated with severe insulin deficiency of Wolfram syndrome …
Wolfram SyndromeDiabetes MellitusOptic Nerve Atrophy+3 more
Estimated
~$10 – $750
Washington University School of MedicineNCT02841553